Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26837,122,1.06 [0.90-1.24],0.4834549037945052
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27595,209,0.89 [0.78-1.01],0.0817642057479034
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27313,1354,1.05 [1.00-1.10],0.0690657052989577
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Candidiasis,27619,479,0.99 [0.91-1.07],0.737533735183925
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26762,3541,1.05 [1.02-1.08],0.0014894514759357
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26994,2915,1.03 [1.00-1.06],0.0794916960154839
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27326,1389,1.04 [0.99-1.09],0.1105006629600556
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27514,93,0.95 [0.78-1.15],0.6000491302566591
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25738,828,1.10 [1.04-1.17],0.0012069214560403
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24909,976,1.05 [0.99-1.11],0.0791880523316482
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24916,266,1.00 [0.89-1.11],0.9357153479384616
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19373,1698,1.06 [1.01-1.10],0.0128394677160506
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24673,379,1.06 [0.97-1.16],0.2201888687311744
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27559,1622,1.01 [0.97-1.06],0.5753273817795739
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Mycoses,27686,546,1.01 [0.93-1.09],0.8490656042313219
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26920,961,1.05 [1.00-1.11],0.0694653487180093
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27629,914,1.10 [1.04-1.17],0.0005706729340216
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26146,209,0.89 [0.78-1.02],0.0858926833974562
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27749,47,1.18 [0.93-1.49],0.1779718091523112
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27516,801,1.10 [1.04-1.17],0.0020146855336641
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27505,84,0.93 [0.76-1.13],0.4516086328540343
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27654,198,1.13 [1.00-1.27],0.0503107786789825
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27635,179,1.09 [0.96-1.24],0.1676894634066156
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26309,350,1.09 [1.00-1.20],0.0542785760999962
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26226,267,1.04 [0.93-1.16],0.49713720808544
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26070,133,0.97 [0.83-1.14],0.7122089108516798
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27727,37,1.08 [0.82-1.42],0.5929329012621678
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27671,164,1.07 [0.93-1.23],0.3232269553331149
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Viral warts,27556,49,1.07 [0.83-1.37],0.6112410645456169
CXCL1,Growth-regulated alpha protein,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27587,80,1.17 [0.97-1.40],0.0969631413846205
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm,27480,241,1.06 [0.95-1.18],0.3278461688828045
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27646,70,1.03 [0.84-1.27],0.7757231061012579
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27642,69,1.15 [0.94-1.40],0.1675599204319012
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27452,1250,1.01 [0.96-1.06],0.68329836833966
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of meninges,27722,82,1.11 [0.92-1.34],0.2610372121025694
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27680,66,1.08 [0.87-1.33],0.4816574520079153
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27716,138,0.96 [0.82-1.12],0.6298464167432416
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm of ovary,27664,179,1.00 [0.87-1.14],0.9703398246264224
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27727,286,0.98 [0.88-1.09],0.6753104761287632
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Caecum,27733,256,1.02 [0.92-1.14],0.684237387000522
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27659,67,0.79 [0.62-1.00],0.053933400106539
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Descending colon,27730,158,0.99 [0.86-1.15],0.9143239756066704
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Rectum,27690,287,1.01 [0.91-1.13],0.788492973064985
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27639,509,0.96 [0.89-1.04],0.3461045763564278
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27728,305,0.98 [0.88-1.08],0.6374701437058825
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Carcinoma in situ of breast,22476,139,0.84 [0.71-0.99],0.0359294903405291
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22564,165,1.03 [0.90-1.19],0.6365801889194767
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22545,31,0.81 [0.57-1.15],0.2317032877491999
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22582,68,0.99 [0.80-1.24],0.9594938871225768
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27680,140,0.96 [0.82-1.12],0.5815785628569847
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Haemangioma, any site",27681,138,0.94 [0.81-1.11],0.4830147573338404
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Leiomyoma of uterus,26746,593,1.07 [0.99-1.15],0.0700892888313118
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Lung cancer and mesothelioma,19906,315,0.95 [0.85-1.06],0.3283698470527038
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Lymphoid leukaemia,22550,36,0.95 [0.69-1.29],0.7254430297324761
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22690,176,1.08 [0.95-1.24],0.2210497446402449
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22631,117,1.06 [0.90-1.25],0.4519251578114087
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22703,189,0.94 [0.83-1.08],0.4027177794353623
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22585,71,1.05 [0.85-1.29],0.6433123524256734
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22587,73,1.23 [1.02-1.48],0.0314883747829905
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22571,57,0.98 [0.77-1.25],0.8716400810683205
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22657,143,0.93 [0.79-1.09],0.3561056114396735
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22617,103,1.03 [0.87-1.22],0.7355246726748486
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22597,83,1.00 [0.82-1.22],0.9716751009562742
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22557,43,0.92 [0.69-1.22],0.5531582137501314
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22596,82,1.05 [0.86-1.27],0.6397304905578031
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanocytic naevi,27480,234,1.13 [1.01-1.26],0.0301873879802443
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanocytic naevi of trunk,27701,82,1.22 [1.02-1.45],0.0301196901353009
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Melanoma in situ,22549,90,0.98 [0.81-1.19],0.8547354838604648
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22597,83,1.00 [0.82-1.22],0.9974932285398044
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22670,156,1.04 [0.90-1.20],0.6022444475167392
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22742,228,0.90 [0.79-1.02],0.1083815309536544
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22611,97,1.08 [0.91-1.29],0.3848330868746121
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,Other benign neoplasms of skin,27519,168,1.04 [0.91-1.19],0.5650239533171093
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23466,952,0.99 [0.93-1.05],0.6437907653983995
CXCL1,Growth-regulated alpha protein,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23505,991,0.99 [0.94-1.05],0.8137778003456748
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27438,379,1.01 [0.92-1.11],0.8159836923768687
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25694,106,1.16 [0.99-1.36],0.0597120351915134
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27130,71,1.07 [0.87-1.32],0.5005295801807501
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26720,3025,1.06 [1.03-1.10],0.0001086807743033
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26073,37,1.09 [0.82-1.44],0.5450023718132222
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27335,48,1.33 [1.08-1.64],0.0084325022340233
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27152,1564,1.08 [1.03-1.12],0.0008371021297012
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27152,1564,1.08 [1.03-1.12],0.0008371021297012
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25659,71,0.90 [0.72-1.13],0.354441778499705
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27333,1297,1.09 [1.04-1.15],0.000257245060686
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27409,122,1.04 [0.89-1.22],0.6089114772728468
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27112,53,0.99 [0.77-1.27],0.9224490058171064
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27116,57,1.14 [0.91-1.41],0.2578127401418326
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27529,242,1.05 [0.94-1.18],0.3539097052343194
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27634,62,1.18 [0.96-1.45],0.1161266903027646
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27492,205,0.99 [0.87-1.12],0.8240824877974586
CXCL1,Growth-regulated alpha protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26172,136,1.08 [0.93-1.25],0.3068823626747096
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22318,259,1.07 [0.96-1.19],0.2469772812589363
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26296,70,0.97 [0.77-1.21],0.7612872252324991
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26292,66,1.03 [0.82-1.29],0.7920577796592814
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22112,53,1.11 [0.88-1.40],0.3680813321000202
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25446,69,0.91 [0.73-1.14],0.4254960104999296
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25069,249,0.99 [0.89-1.12],0.9304549480804236
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27305,511,0.95 [0.87-1.03],0.2041963256982798
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27087,293,1.02 [0.92-1.13],0.7014851543750877
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26880,86,1.00 [0.82-1.21],0.9645956547199293
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27346,1969,0.99 [0.95-1.03],0.7308188278915353
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24538,1919,0.99 [0.95-1.03],0.6636539738995726
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22119,60,1.07 [0.86-1.33],0.5594909038480809
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24612,118,0.99 [0.84-1.17],0.8717453748038361
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22347,288,1.06 [0.96-1.18],0.2228670747075742
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22107,48,1.11 [0.86-1.41],0.4233997475911085
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25248,3189,1.02 [0.99-1.05],0.2084286293983083
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22265,206,1.00 [0.88-1.13],0.9514873146128648
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22606,547,1.04 [0.97-1.12],0.2591711737154494
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27644,377,1.07 [0.98-1.17],0.1467983951251655
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27453,186,1.11 [0.98-1.26],0.086874802654986
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22161,102,0.96 [0.80-1.15],0.6206888987174526
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22113,54,1.25 [1.02-1.54],0.0323381302374367
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26850,2356,1.04 [1.00-1.08],0.0273422833196749
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22275,216,1.09 [0.97-1.22],0.1463320350630497
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22280,221,1.19 [1.07-1.32],0.0011588923340956
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22599,540,1.02 [0.94-1.10],0.6586940917568258
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22154,95,1.06 [0.89-1.27],0.4805919543779544
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27443,176,1.09 [0.96-1.24],0.1713145834185537
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22693,634,1.02 [0.95-1.09],0.5890494022288262
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22633,574,0.98 [0.91-1.06],0.636008831726966
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24890,70,1.11 [0.90-1.35],0.3288084545518973
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26831,4772,1.03 [1.00-1.06],0.0249517678145368
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24570,76,1.02 [0.83-1.24],0.8734599106505723
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24582,88,1.00 [0.82-1.21],0.9841914834526556
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27545,2113,0.99 [0.96-1.03],0.7960732135371889
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27550,2112,0.99 [0.96-1.03],0.7868135920654447
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24573,79,1.06 [0.87-1.28],0.5783062166724866
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27332,1610,1.00 [0.96-1.05],0.9677670195140008
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23611,1552,1.03 [0.99-1.08],0.1345365628864718
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27734,189,1.13 [1.01-1.28],0.040006726600205
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26852,58,1.10 [0.88-1.37],0.4133348999982469
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25856,134,0.98 [0.84-1.15],0.8187587143852563
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25921,199,1.03 [0.91-1.17],0.6252253760800162
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22330,271,1.17 [1.06-1.29],0.002071458375804
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25893,144,1.18 [1.03-1.35],0.0169564975443938
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1731,49,0.96 [0.73-1.25],0.7401908129444905
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1846,187,1.04 [0.92-1.18],0.5140342773944144
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25774,25,1.30 [0.98-1.73],0.070821483365675
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1713,32,1.15 [0.87-1.52],0.3410277377636832
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27251,1502,1.03 [0.98-1.08],0.2051701786183377
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27138,344,0.94 [0.85-1.04],0.2110034627089586
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25313,493,0.98 [0.90-1.06],0.594662092028719
CXCL1,Growth-regulated alpha protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22806,747,1.06 [0.99-1.12],0.0895519476963858
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27646,235,0.92 [0.81-1.04],0.1711805749165093
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26720,56,0.87 [0.67-1.12],0.2801427538467624
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Angina pectoris,26185,897,1.00 [0.94-1.06],0.9359582255682918
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26765,101,0.89 [0.73-1.07],0.2143828292648686
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26697,33,1.19 [0.89-1.58],0.2343085689987511
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26818,154,1.01 [0.87-1.16],0.9405477842414852
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18033,1513,1.03 [0.98-1.07],0.2804433904863038
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,AV-block,24279,247,1.08 [0.97-1.21],0.1656236003708183
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27705,309,0.95 [0.86-1.06],0.3440516424934969
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cardiac arrest,16652,132,1.16 [1.01-1.33],0.0396172431453502
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24171,139,0.91 [0.78-1.07],0.2743828932660926
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24114,82,1.02 [0.83-1.24],0.8629626087197055
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27744,34,1.12 [0.84-1.51],0.4377544947766332
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Conduction disorders,24777,745,1.04 [0.98-1.11],0.1834551264461662
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26816,1540,1.01 [0.97-1.06],0.5248305565456888
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24942,7361,1.03 [1.01-1.06],0.0013128325210593
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26200,250,0.93 [0.83-1.05],0.263155900079301
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Endocarditis,24095,63,1.12 [0.91-1.38],0.2993588099951787
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27648,867,1.05 [0.99-1.12],0.078317513828584
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypertension,25572,6224,1.03 [1.01-1.05],0.0069274600198254
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25583,6235,1.03 [1.01-1.05],0.0079975050490859
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27633,45,1.14 [0.90-1.46],0.2804443600672189
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19515,167,1.02 [0.89-1.18],0.7542822282191215
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19453,105,1.12 [0.95-1.32],0.1745787752820511
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Hypotension,27603,1127,1.00 [0.95-1.05],0.917585859165002
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26983,95,1.26 [1.08-1.47],0.003990278087523
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27015,1727,1.02 [0.97-1.06],0.4298711639286703
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27428,461,1.02 [0.94-1.11],0.6389867945561034
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24335,303,1.05 [0.95-1.16],0.3319223227052777
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27522,616,1.02 [0.95-1.10],0.5796395293880658
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25783,495,1.03 [0.96-1.12],0.4016765919564767
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27722,87,1.12 [0.93-1.34],0.232550889646705
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27742,246,1.05 [0.94-1.17],0.4088709357391835
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Oesophageal varices,25989,39,1.10 [0.84-1.44],0.5020712001119831
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other aneurysm,26725,61,0.87 [0.68-1.12],0.2874226865398934
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other arrhythmias,24395,363,1.07 [0.98-1.17],0.1439935694657074
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26730,66,1.23 [1.01-1.49],0.0407317395975796
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26859,195,0.93 [0.82-1.07],0.3027132275523525
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24191,159,0.97 [0.84-1.13],0.723738628375939
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other disorders of veins,26047,97,1.11 [0.93-1.32],0.236869880791757
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25996,46,0.92 [0.70-1.22],0.5715566059343415
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26483,39,0.89 [0.66-1.21],0.4490638829385364
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26117,167,0.98 [0.85-1.13],0.7644730111726818
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24861,829,1.03 [0.97-1.10],0.2796937971379532
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26520,44,0.99 [0.76-1.30],0.9596487143810586
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27175,511,1.02 [0.95-1.11],0.5722240944616134
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27169,324,0.97 [0.87-1.07],0.5370753164514983
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26996,552,0.98 [0.91-1.06],0.6737769150372988
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16812,292,0.99 [0.89-1.10],0.800222357757973
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26931,281,0.99 [0.89-1.10],0.8466889868169194
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26282,332,0.97 [0.88-1.08],0.6032642503752489
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27292,447,1.06 [0.97-1.15],0.1769372429045377
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27670,600,0.97 [0.90-1.05],0.4292598457322366
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24261,229,1.05 [0.93-1.18],0.4147647346825385
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27161,316,0.97 [0.88-1.08],0.6185007532550628
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26607,163,0.95 [0.83-1.10],0.5214787735013877
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27422,534,1.05 [0.97-1.13],0.2165676228114195
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27396,582,1.05 [0.98-1.13],0.1812507782272728
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26947,70,1.12 [0.91-1.37],0.284946281554237
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26712,48,0.83 [0.62-1.10],0.1961194817710628
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27186,219,1.02 [0.90-1.15],0.7623035995477582
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27108,202,1.00 [0.88-1.14],0.9718145980822948
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Varicose veins,26419,469,1.02 [0.94-1.11],0.618532377589954
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26675,96,0.99 [0.82-1.20],0.9428983309502744
CXCL1,Growth-regulated alpha protein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27532,711,1.04 [0.97-1.11],0.2777440744543871
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27701,224,1.05 [0.94-1.18],0.3915896435561795
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24632,1877,1.00 [0.96-1.04],0.8904328199833716
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Any mental disorder,27128,4373,1.00 [0.97-1.03],0.9755500687676266
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27669,266,1.02 [0.91-1.14],0.7081980067071629
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24746,1991,0.99 [0.95-1.03],0.5976833850596397
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22848,93,1.02 [0.85-1.23],0.7984427722040847
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Smoking dependency,27332,1215,0.99 [0.94-1.04],0.6981442926707091
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24159,1404,0.99 [0.94-1.04],0.7843777639127385
CXCL1,Growth-regulated alpha protein,Chapter V Mental and behavioural disorders,Vascular dementia,27238,101,0.88 [0.72-1.06],0.1817922436756571
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Alzheimer disease,27748,363,1.05 [0.96-1.16],0.267220732312465
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18925,59,1.03 [0.83-1.29],0.7644839605866116
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Bell's palsy,25557,87,1.11 [0.93-1.33],0.2370209999111671
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26115,645,1.00 [0.93-1.08],0.9509853269460656
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Cerebral cysts,27335,220,1.03 [0.91-1.16],0.6493701356915031
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27675,282,1.03 [0.93-1.15],0.5618684955560029
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27261,40,0.83 [0.61-1.13],0.2322252924912887
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27735,47,0.96 [0.74-1.26],0.7928514428013129
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27170,55,1.00 [0.79-1.28],0.9849437558094912
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Epilepsy,26236,281,1.04 [0.93-1.15],0.4990723236165234
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27326,1371,1.04 [0.99-1.09],0.1016128228917595
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27698,517,1.02 [0.94-1.10],0.6907506431748823
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27101,2944,0.99 [0.96-1.02],0.60309610573076
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Generalized epilepsy,27375,44,1.07 [0.82-1.39],0.6022138320520235
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Hemiplegia,27620,227,1.06 [0.94-1.19],0.3170359314171191
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Hydrocephalus,27179,64,1.05 [0.85-1.32],0.6348751562343037
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27728,75,1.10 [0.90-1.34],0.3387399183301505
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25600,130,0.99 [0.85-1.16],0.9268279037301296
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25537,67,1.14 [0.93-1.40],0.2030190851420431
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Memory loss,27112,96,1.12 [0.94-1.33],0.2123942001677625
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Migraine,26479,524,1.07 [0.99-1.15],0.0876212280414
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27633,470,1.07 [0.99-1.16],0.1044965655781299
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Motor neuron disease,19014,121,1.02 [0.87-1.20],0.805792499457644
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27529,143,1.05 [0.90-1.21],0.557335157897662
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26887,1417,1.02 [0.98-1.07],0.3290445915513834
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Neurological diseases,26114,3863,1.02 [0.99-1.05],0.1538785065797546
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27376,155,0.96 [0.83-1.12],0.6037300209615151
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25899,429,1.04 [0.95-1.13],0.3726969328131155
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27690,239,1.07 [0.96-1.19],0.2483035183414617
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22333,667,1.02 [0.95-1.09],0.6133429350553121
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27185,70,0.93 [0.75-1.16],0.5246076790993213
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27239,124,0.86 [0.73-1.03],0.095549184694677
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27367,186,1.03 [0.91-1.18],0.6241190682462917
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25567,97,1.11 [0.94-1.32],0.2219309661139459
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other headache syndromes,26032,77,1.10 [0.91-1.34],0.3095939622349672
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other neurological diseases,27626,511,1.01 [0.93-1.09],0.8018449712179152
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Other sleep disorders,26367,412,0.97 [0.88-1.06],0.4703894302439861
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Parkinson's disease,27723,315,0.98 [0.89-1.09],0.7565089702129029
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27200,85,1.01 [0.83-1.22],0.9537379691890856
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Restless leg syndrome,27747,102,1.05 [0.88-1.25],0.5683581721755164
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Sleep apnoea,27566,325,0.96 [0.87-1.07],0.456564550330805
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27491,40,1.18 [0.91-1.52],0.2168631373572154
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27738,150,0.92 [0.79-1.07],0.2745375792105037
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25538,68,0.91 [0.72-1.15],0.4237451517268232
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27748,367,1.06 [0.96-1.16],0.2496156865022545
CXCL1,Growth-regulated alpha protein,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27195,98,0.88 [0.72-1.07],0.1941726354619941
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27155,113,0.95 [0.80-1.13],0.5583430788619281
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27277,490,1.00 [0.92-1.08],0.9878071540707296
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27601,176,1.06 [0.93-1.20],0.4127337657320454
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26626,63,0.86 [0.68-1.10],0.2349561805446862
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26615,52,1.02 [0.80-1.31],0.8698665470698586
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27623,63,1.14 [0.93-1.41],0.2126963889252728
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27454,168,0.97 [0.85-1.12],0.7221853545996357
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1719,37,1.18 [0.91-1.53],0.2004902749029024
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2068,71,0.86 [0.69-1.08],0.1902890581207252
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27137,95,0.93 [0.77-1.12],0.4469947513956355
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27564,1070,1.01 [0.95-1.06],0.8510932597975901
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27327,764,0.92 [0.86-0.99],0.0167940747011031
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26864,301,0.93 [0.84-1.04],0.2130927582463037
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27654,867,0.96 [0.90-1.02],0.1659451479829614
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27731,71,0.92 [0.74-1.15],0.4860700961732769
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27577,790,0.97 [0.91-1.03],0.2998718845351411
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27700,414,1.04 [0.95-1.13],0.39598469135683
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27651,211,0.79 [0.69-0.90],0.0004661846688918
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26605,42,0.93 [0.70-1.24],0.635987342445937
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26612,49,1.13 [0.89-1.43],0.3284988163830683
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26629,66,0.84 [0.66-1.06],0.1419126250578405
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27656,734,0.97 [0.91-1.04],0.3617208752446564
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27109,187,0.97 [0.85-1.11],0.7039057766104682
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26855,68,1.05 [0.85-1.29],0.6739974779814683
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27391,105,1.03 [0.86-1.22],0.7763915404520776
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27604,318,1.04 [0.94-1.15],0.4310420712973717
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27003,216,0.87 [0.76-0.99],0.0343327211925671
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27579,139,0.75 [0.63-0.89],0.0007989278764816
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27405,483,1.01 [0.93-1.10],0.7447121232205975
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27192,150,0.92 [0.79-1.07],0.2908929009598203
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25920,2539,0.98 [0.94-1.01],0.1705597431398132
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27562,276,1.02 [0.92-1.13],0.7277443998356097
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27722,158,1.06 [0.93-1.22],0.3731928849069309
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26964,401,0.97 [0.89-1.07],0.5537340542735469
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27351,65,0.96 [0.76-1.21],0.7132894722292986
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27716,56,0.92 [0.71-1.18],0.5105483909396569
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26653,90,0.69 [0.55-0.86],0.0008198866429332
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26719,156,1.02 [0.89-1.18],0.764270835902392
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26604,110,1.04 [0.88-1.23],0.6514073810175347
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26858,71,0.79 [0.62-1.00],0.0530162407647609
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26554,60,0.68 [0.52-0.89],0.0043385781540357
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27043,121,0.80 [0.67-0.96],0.0143669260108608
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27105,183,0.96 [0.84-1.10],0.5971281256317282
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26699,136,0.90 [0.77-1.06],0.2158602684793627
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26595,101,0.96 [0.80-1.15],0.6717156151730614
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26571,77,1.19 [1.00-1.43],0.0541949292124909
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25512,2131,0.99 [0.95-1.03],0.4786492100325544
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26649,86,0.83 [0.67-1.03],0.0850226523171978
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27478,436,0.94 [0.86-1.02],0.1496049346653889
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27091,49,1.00 [0.77-1.29],0.9970310272236848
CXCL1,Growth-regulated alpha protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27213,171,1.06 [0.93-1.21],0.3888663364601715
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27501,117,0.94 [0.79-1.11],0.4757681417150941
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27702,120,1.01 [0.86-1.19],0.9302916009922232
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27620,145,1.15 [1.00-1.32],0.047100390728453
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27453,69,1.13 [0.92-1.38],0.2387350025700617
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,27457,73,1.00 [0.81-1.23],0.972448693024781
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27646,822,1.01 [0.95-1.07],0.789231687040576
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27389,565,1.02 [0.95-1.10],0.554562699727125
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26946,122,1.05 [0.90-1.23],0.5136922835932225
CXCL1,Growth-regulated alpha protein,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26911,87,1.03 [0.85-1.25],0.7467342676844377
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute pharyngitis,27472,86,0.94 [0.77-1.15],0.5684296380803754
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27621,235,0.94 [0.84-1.06],0.3503845384485611
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27450,64,1.01 [0.81-1.27],0.91119723292195
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,All influenza,26002,129,1.03 [0.89-1.21],0.6653630310103286
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26000,127,1.05 [0.90-1.23],0.5106913776396297
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19721,130,1.04 [0.89-1.21],0.628162334056189
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Allergic rhinitis,27590,291,1.03 [0.93-1.14],0.5896456039150397
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21490,2091,1.04 [1.00-1.08],0.073822126743093
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21655,2064,1.04 [1.00-1.08],0.0619469475860582
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27325,126,1.06 [0.91-1.24],0.4544148022159606
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25941,68,0.92 [0.74-1.15],0.4762403299861514
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Bronchiectasis,23992,414,1.14 [1.05-1.24],0.0019166103442353
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23649,71,1.00 [0.81-1.24],0.995532442110586
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26584,3006,1.04 [1.01-1.07],0.0197471838658971
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26446,62,1.05 [0.84-1.31],0.6504838397170515
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Chronic sinusitis,26531,147,1.03 [0.89-1.20],0.650949754788909
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27572,1079,0.99 [0.93-1.04],0.647390238144582
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Deviated nasal septum,26457,73,1.01 [0.81-1.24],0.9610880748717436
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25630,5211,1.04 [1.02-1.07],0.0008261088586671
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26720,336,1.03 [0.94-1.14],0.5053001177202086
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Early onset COPD,26816,323,0.97 [0.88-1.08],0.6111044344952186
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Emphysema,23857,279,1.06 [0.95-1.19],0.2769227205119459
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26093,236,1.08 [0.96-1.21],0.1924702536513297
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27552,1679,1.05 [1.00-1.09],0.0318038366179894
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Interstitial lung disease,26134,277,1.08 [0.97-1.20],0.1488295883643615
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Later onset COPD,26818,756,1.00 [0.93-1.06],0.9019338912780372
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27741,231,1.03 [0.91-1.15],0.6561039150809803
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Nasal polyp,26453,69,0.90 [0.72-1.13],0.3693533279369241
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27515,929,1.04 [0.98-1.10],0.1854466969442383
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other diseases of pleura,27554,1770,1.06 [1.02-1.11],0.0045766538013898
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27181,797,1.03 [0.97-1.10],0.3290824549434543
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other pleural conditions,25820,36,0.87 [0.63-1.20],0.3818012317915016
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27666,353,1.04 [0.95-1.14],0.4132825663367514
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27657,1194,1.05 [1.00-1.10],0.0744918057366194
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pleural effusion,26642,858,1.07 [1.01-1.13],0.0306216604312034
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pleural plaque,25831,47,1.07 [0.83-1.38],0.5935214805346094
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27317,1444,1.05 [1.00-1.10],0.059717379272935
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27711,201,1.04 [0.92-1.18],0.5380867447239293
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pneumothorax,25877,93,1.08 [0.90-1.30],0.3895727989291411
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pollen allergy,27716,243,1.01 [0.90-1.13],0.8570539166894783
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Pulmonary oedema,27378,65,0.93 [0.74-1.17],0.5432296123712009
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19644,53,1.08 [0.85-1.37],0.5138999262605741
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27490,904,1.03 [0.98-1.10],0.2514649731575861
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26675,291,1.03 [0.93-1.14],0.5724221934698963
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Viral pneumonia,26089,216,1.00 [0.89-1.13],0.9439679016913272
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27335,169,0.99 [0.86-1.13],0.8363535308359498
CXCL1,Growth-regulated alpha protein,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13397,110,1.01 [0.86-1.20],0.8634617469281151
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19755,37,1.10 [0.83-1.45],0.5193068865784748
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute appendicitis,27559,144,0.93 [0.80-1.09],0.3547641780558938
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute gastritis,20800,91,1.08 [0.90-1.30],0.3962922716984729
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute pancreatitis,25414,163,1.19 [1.05-1.35],0.0075814770944942
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Acute peritonitis,27161,90,1.15 [0.96-1.36],0.1252218537999038
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26857,35,0.94 [0.68-1.29],0.6985704016806891
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Barrett oesophagus,21049,340,1.05 [0.95-1.15],0.3591150188781036
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25331,80,1.24 [1.04-1.47],0.0159811572772536
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27309,80,1.23 [1.04-1.47],0.0175351377868233
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Cholecystitis,25442,191,0.95 [0.83-1.08],0.4260576811409454
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Cholelithiasis,26452,1201,1.06 [1.00-1.11],0.0336217110513113
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Chronic gastritis,21052,343,1.07 [0.98-1.18],0.1467109577167316
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25293,42,1.21 [0.95-1.55],0.1283440455234171
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27662,74,1.10 [0.90-1.34],0.3394769717984359
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Coeliac disease,26163,154,1.17 [1.02-1.33],0.0208080904878222
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Collagenous colitis,25817,115,0.97 [0.82-1.15],0.7155710011802079
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27606,152,1.10 [0.96-1.26],0.1790214060312115
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Constipation,27398,1750,1.03 [0.99-1.08],0.1192585079595597
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Crohn disease,25798,96,1.08 [0.90-1.28],0.4187249341550052
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27381,72,1.08 [0.88-1.33],0.4577046791182088
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25802,100,0.99 [0.83-1.19],0.956584727258698
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Dental caries,26903,236,0.98 [0.87-1.10],0.7344856968455218
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26102,2503,1.04 [1.00-1.08],0.0380018296041075
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of appendix,27602,187,0.97 [0.85-1.11],0.6907464757802892
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of liver,27647,825,1.06 [1.00-1.13],0.0625991852930845
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25418,4709,1.02 [0.99-1.05],0.1640814220419379
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27268,601,0.99 [0.92-1.07],0.8926263457966168
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27623,552,1.07 [0.99-1.15],0.07412667173875
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26786,119,0.95 [0.80-1.12],0.536190219856535
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26631,66,0.88 [0.70-1.12],0.3016075511171328
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27443,1434,1.02 [0.97-1.07],0.4390045141475476
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diseases of tongue,26643,114,1.03 [0.87-1.21],0.7479032252785651
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26865,1614,1.06 [1.02-1.11],0.0046657200977144
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22978,3260,1.02 [0.99-1.05],0.2551121564043356
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Duodenal ulcer,20842,133,1.03 [0.88-1.19],0.7465376147621485
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27697,112,1.01 [0.86-1.20],0.8823411907026465
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27642,63,1.10 [0.88-1.36],0.402836448476022
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26918,96,1.19 [1.01-1.40],0.0389436738035143
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19832,114,1.16 [1.00-1.35],0.0554753721327944
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Functional dyspepsia,21375,666,1.03 [0.97-1.11],0.3445572608555802
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastric ulcer,21060,351,1.01 [0.92-1.11],0.7900846057059812
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23557,2848,1.01 [0.97-1.04],0.7045143165568024
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21186,477,1.00 [0.92-1.09],0.9416633795661312
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21686,8579,1.02 [1.00-1.04],0.0747865540455769
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,GI-bleeding,27168,1159,1.00 [0.94-1.05],0.8535875448966402
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26731,64,0.72 [0.56-0.93],0.0113478185854383
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20704,1279,1.04 [0.99-1.09],0.153126267122337
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26863,41,1.01 [0.76-1.33],0.9573950549531364
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Hernia,26543,2944,1.03 [1.00-1.07],0.0594114218054035
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Impacted teeth,27653,58,1.11 [0.89-1.39],0.3497091426269467
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Impaction of intestines,19783,65,1.22 [1.01-1.49],0.0422415233280171
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Inguinal hernia,23770,171,0.96 [0.84-1.11],0.6087589924942547
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19823,105,1.15 [0.98-1.35],0.0821346773613736
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26190,181,1.11 [0.97-1.25],0.1216611838711586
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20550,832,1.02 [0.96-1.08],0.5495606796166811
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27732,364,1.12 [1.03-1.23],0.0086613244319193
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26534,832,1.04 [0.98-1.11],0.1756143812413519
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26826,1124,1.03 [0.98-1.09],0.2075919314990749
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20872,163,1.09 [0.95-1.24],0.2273256868255479
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oesophagitis,21286,577,1.05 [0.98-1.13],0.1889365449471776
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27702,160,1.12 [0.98-1.28],0.0957457296215966
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23660,61,1.05 [0.84-1.31],0.6680697501499573
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21004,1286,1.00 [0.95-1.05],0.8869009397745904
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25556,305,1.09 [0.99-1.21],0.0746331310307451
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25441,190,1.03 [0.90-1.17],0.6838805927125018
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of intestine,21332,1614,0.99 [0.95-1.04],0.7806673401814059
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of intestines,25531,5813,1.01 [0.99-1.03],0.4741902482990981
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26636,237,1.07 [0.95-1.19],0.2606420265598804
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of liver,27515,693,1.06 [0.99-1.13],0.0772821268356773
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21297,588,1.05 [0.97-1.12],0.2321658241368974
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25411,160,1.00 [0.87-1.15],0.9921250018137896
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27557,486,1.05 [0.97-1.14],0.215359291199658
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21800,1091,1.03 [0.97-1.08],0.327771506491733
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27187,1178,1.00 [0.94-1.05],0.8653460323574645
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26865,198,0.99 [0.87-1.13],0.9055919957373753
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21526,1808,1.04 [1.00-1.08],0.0712596161397075
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22861,2152,1.02 [0.98-1.06],0.2817192247830655
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26925,103,1.09 [0.92-1.29],0.3406303113690224
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26688,986,1.02 [0.96-1.08],0.4787314813698506
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20054,336,1.06 [0.96-1.16],0.2546531788025452
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27631,73,1.11 [0.90-1.35],0.3273066295964378
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20221,503,1.07 [0.99-1.15],0.0982651158458995
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26142,133,1.04 [0.90-1.21],0.5905749427316309
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27740,69,0.84 [0.67-1.07],0.1561914237476605
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26669,129,0.92 [0.78-1.09],0.3296740350853029
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Toxic colitis,25770,68,0.95 [0.76-1.19],0.632189656014013
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20944,235,1.08 [0.96-1.21],0.1961705886409941
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ulcerative colitis,25875,173,1.12 [0.99-1.27],0.0816850909197585
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25843,141,1.15 [1.00-1.32],0.0564637518605767
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Umbilical hernia,23770,171,0.88 [0.76-1.02],0.0955410090406834
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19911,193,1.04 [0.92-1.18],0.5232426243971566
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Ventral hernia,23860,261,1.04 [0.94-1.17],0.4328876223880005
CXCL1,Growth-regulated alpha protein,Chapter XI Diseases of the digestive system,Volvulus,19806,88,0.88 [0.72-1.08],0.2171729860371293
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27658,263,1.05 [0.95-1.17],0.3433792022082877
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27423,77,0.92 [0.74-1.13],0.4235021277849959
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25655,224,0.93 [0.82-1.06],0.2680037717474108
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27205,645,1.05 [0.98-1.12],0.1970389547440598
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26708,148,0.99 [0.85-1.15],0.9015861238627056
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25777,346,1.05 [0.96-1.16],0.2799932169348941
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27429,284,1.05 [0.95-1.16],0.3670853841393401
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27636,491,1.07 [0.99-1.15],0.1075290843094909
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27197,52,1.10 [0.87-1.40],0.4169476485264372
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26122,3216,1.00 [0.97-1.03],0.9176094625214536
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27291,486,0.93 [0.85-1.01],0.0747482072521574
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27139,334,0.91 [0.82-1.01],0.0629666523298149
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27422,862,1.01 [0.95-1.08],0.6777510161417734
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27724,79,1.05 [0.86-1.28],0.6240942584398947
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25522,91,0.98 [0.81-1.18],0.8336507116618675
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26851,46,1.03 [0.80-1.34],0.8012427952953334
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27414,269,1.04 [0.94-1.16],0.4605203418658352
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25854,423,1.06 [0.97-1.15],0.2136213459293939
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25480,49,1.09 [0.85-1.39],0.5084714086311728
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27640,84,0.92 [0.75-1.13],0.4171630970087969
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26719,159,1.16 [1.02-1.32],0.0263826690476087
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27515,169,0.88 [0.76-1.02],0.0790074182872549
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27202,57,1.10 [0.88-1.38],0.3978851012467594
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25498,67,0.99 [0.80-1.24],0.954823399970662
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27051,1620,1.02 [0.98-1.07],0.3509484965259973
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25889,458,1.05 [0.97-1.14],0.2316110885014023
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25485,54,1.10 [0.87-1.39],0.4148949570322049
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27661,315,0.94 [0.85-1.05],0.2766675477732083
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27231,86,1.12 [0.94-1.34],0.2113312766943145
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27586,240,0.92 [0.82-1.04],0.195464511423497
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27695,300,1.03 [0.93-1.14],0.5647606545318284
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25593,162,1.00 [0.86-1.15],0.9617395926409767
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25695,264,0.91 [0.81-1.02],0.100014341055114
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27680,285,1.02 [0.92-1.14],0.6898182410668786
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25634,203,1.09 [0.97-1.23],0.1405553294417119
CXCL1,Growth-regulated alpha protein,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27711,155,0.98 [0.85-1.14],0.7981177871325985
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23670,126,1.13 [0.98-1.32],0.0954488109108987
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25192,6485,1.00 [0.98-1.03],0.798322915548229
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23775,5068,1.01 [0.98-1.03],0.5956938357809447
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23624,80,0.96 [0.79-1.18],0.7235146748198806
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23791,155,0.92 [0.79-1.07],0.2657664019097217
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23850,214,0.94 [0.83-1.06],0.3185485655501047
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27451,116,0.93 [0.78-1.10],0.381951102784028
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23756,120,0.96 [0.81-1.13],0.6111372885238529
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20097,1390,1.02 [0.97-1.07],0.4747748592634047
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27594,220,0.95 [0.84-1.08],0.4660029815224071
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24258,622,1.02 [0.95-1.09],0.6085036359902101
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23313,8238,1.01 [0.99-1.03],0.4600870029371563
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24847,143,1.04 [0.90-1.20],0.6157906516044835
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23681,137,1.05 [0.91-1.22],0.4881164960432312
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24242,698,1.03 [0.96-1.10],0.3810582399479927
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26719,3083,0.99 [0.95-1.02],0.3943403814730865
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23723,179,0.98 [0.86-1.12],0.7849761348680814
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23930,386,1.08 [0.99-1.18],0.08648391532231
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23717,173,1.04 [0.91-1.19],0.5289411705143253
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26776,106,0.89 [0.74-1.07],0.2189802854500849
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20615,1908,1.00 [0.96-1.04],0.9582501898313522
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18936,229,1.07 [0.96-1.20],0.2002137102479616
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27735,226,1.07 [0.95-1.20],0.2564446424662887
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18809,102,1.18 [1.01-1.39],0.0397148143503416
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19281,574,0.95 [0.88-1.03],0.1866239358780778
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23875,331,0.96 [0.87-1.06],0.409456240827483
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19353,646,0.91 [0.85-0.98],0.017570493142229
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23705,69,1.07 [0.87-1.32],0.5036141318059719
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24363,727,0.99 [0.93-1.06],0.7981469381369604
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23972,336,1.06 [0.96-1.17],0.2290963015430133
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19309,602,0.92 [0.85-0.99],0.0339467801525896
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23638,94,1.15 [0.97-1.36],0.1162830253819032
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23613,69,1.06 [0.86-1.31],0.571184797157622
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24753,49,1.15 [0.91-1.46],0.2403544747631359
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27258,2554,1.01 [0.97-1.04],0.7538069681449855
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26541,1837,1.00 [0.96-1.05],0.8205480593627447
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27546,613,1.09 [1.01-1.17],0.0177133804531748
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21808,3101,1.00 [0.97-1.04],0.8441839183814459
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18782,75,0.97 [0.78-1.19],0.7525946028600742
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23649,105,1.05 [0.88-1.24],0.5886834874638481
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18751,44,0.93 [0.70-1.23],0.6046516700207292
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18912,205,0.94 [0.82-1.07],0.3404210567448857
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25000,296,0.96 [0.86-1.06],0.3981206617162661
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25303,599,1.04 [0.97-1.12],0.3098810315520534
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27717,113,1.11 [0.94-1.30],0.2068210527200508
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25714,2078,1.00 [0.96-1.04],0.8853154535227304
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23677,133,0.87 [0.74-1.03],0.1015152310787088
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18937,230,1.00 [0.89-1.13],0.9652374254145988
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24463,827,1.05 [0.99-1.12],0.0881589478939005
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21289,2582,1.00 [0.96-1.03],0.841278200017126
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26802,132,0.91 [0.77-1.08],0.2757409890775384
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27730,76,0.96 [0.78-1.18],0.6933878228079771
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23627,83,0.96 [0.78-1.17],0.6599121364293672
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25050,1506,1.06 [1.01-1.10],0.01547904404596
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23628,84,1.12 [0.93-1.34],0.2431362044121971
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20732,2025,1.03 [1.00-1.08],0.0852879547598116
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24841,137,0.94 [0.80-1.10],0.4158190366386813
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23607,63,1.00 [0.80-1.26],0.9695471826958336
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23843,207,0.95 [0.84-1.08],0.4597302624860875
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24147,603,1.04 [0.97-1.11],0.3276221895739515
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27184,514,1.11 [1.03-1.20],0.0042905210454112
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24295,659,0.97 [0.90-1.04],0.3561877449511262
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27561,593,1.09 [1.02-1.17],0.0135240345175854
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27719,69,1.13 [0.93-1.39],0.2224749053693596
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23770,226,0.98 [0.87-1.11],0.7867235975396241
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21281,940,1.02 [0.96-1.08],0.5858613411445632
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24221,677,1.05 [0.98-1.12],0.1571659656801039
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23668,124,1.01 [0.85-1.18],0.9453809222541324
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18784,77,0.90 [0.73-1.12],0.3466055900805982
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21397,2690,1.03 [1.00-1.07],0.090885050905726
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19569,862,1.02 [0.96-1.09],0.4533936470713388
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26970,300,1.11 [1.01-1.23],0.0322669419554048
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27689,85,1.08 [0.90-1.31],0.4047158247850067
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25409,57,1.09 [0.87-1.37],0.4427860657996312
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18784,77,0.96 [0.78-1.19],0.7291708629692845
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23749,113,1.08 [0.92-1.27],0.331588962399727
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19323,616,1.08 [1.01-1.16],0.0246683111604889
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23884,340,0.97 [0.88-1.08],0.6120023438130706
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23928,292,1.06 [0.96-1.18],0.2384529787378773
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23922,286,1.01 [0.91-1.13],0.7879030581617477
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21408,86,1.11 [0.92-1.33],0.2709348254027096
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27725,75,1.03 [0.84-1.27],0.771565748008162
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24189,645,0.99 [0.93-1.07],0.8423204872689238
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26836,166,1.13 [1.00-1.29],0.056136145971691
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26408,2864,1.03 [0.99-1.06],0.1010981986966887
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23699,155,0.88 [0.75-1.02],0.0942154783812475
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24223,587,1.02 [0.95-1.10],0.6030362210128184
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26001,273,0.95 [0.85-1.06],0.393588202948769
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23922,286,1.00 [0.90-1.11],0.9819110812882528
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25432,1796,0.98 [0.94-1.02],0.3279250365771797
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24851,1215,0.99 [0.94-1.04],0.7110600348152949
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23611,67,1.10 [0.89-1.35],0.3714895469680521
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26899,229,1.05 [0.94-1.18],0.382275169383406
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23753,209,1.07 [0.95-1.21],0.2578567222996545
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23671,127,0.88 [0.75-1.05],0.1505412575204812
CXCL1,Growth-regulated alpha protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18761,54,1.22 [0.99-1.51],0.0597681945838429
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26652,1282,1.09 [1.04-1.14],0.0005910596809569
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20775,103,1.16 [0.98-1.36],0.084791790733647
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27033,109,0.92 [0.77-1.10],0.363532384238511
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27585,239,1.11 [1.00-1.24],0.0608268535736128
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27373,27,0.72 [0.48-1.06],0.0985627409637942
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26887,1517,1.05 [1.01-1.10],0.0258985374592632
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27569,81,1.22 [1.03-1.45],0.0231877022055985
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27534,250,1.06 [0.95-1.19],0.2825079645349234
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Cystitis,24472,258,1.04 [0.93-1.16],0.4850686177122002
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Dialysis,25425,55,1.33 [1.10-1.62],0.0038765382199915
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27263,339,0.95 [0.86-1.05],0.3329589347040433
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Endometriosis,20854,182,1.07 [0.94-1.21],0.3400777814187539
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21074,402,1.03 [0.94-1.13],0.5006860690295424
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21694,1022,1.03 [0.98-1.09],0.2845996279573975
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21591,5129,1.03 [1.00-1.05],0.0435190714912691
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27553,65,1.35 [1.13-1.61],0.0010379582823955
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25247,213,1.02 [0.91-1.16],0.6940310273554967
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27195,404,1.03 [0.94-1.12],0.5825721809193807
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Irregular menses,27274,129,1.08 [0.93-1.26],0.3020635628836167
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20982,310,1.07 [0.96-1.18],0.2208612250576925
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24289,75,1.08 [0.88-1.32],0.4643948381342386
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23156,2484,1.01 [0.97-1.05],0.6370051733377672
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20815,143,1.08 [0.93-1.25],0.3208471145599597
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27734,67,1.03 [0.83-1.28],0.7573727232300707
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27737,76,1.11 [0.91-1.34],0.3088264955227929
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26478,2264,1.05 [1.01-1.09],0.0169817378426311
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24695,481,0.99 [0.91-1.07],0.7402680314037582
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27044,120,0.92 [0.78-1.09],0.3482689749976467
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27683,399,1.06 [0.97-1.16],0.1685142023191262
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27686,93,1.06 [0.88-1.27],0.541437491064529
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26156,1942,1.05 [1.01-1.09],0.0201810301948201
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27000,209,1.07 [0.95-1.21],0.2538480808449503
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20828,156,1.02 [0.89-1.18],0.7625722152544487
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21044,372,0.97 [0.88-1.07],0.5407161515533152
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20786,114,1.04 [0.88-1.23],0.6226979103929742
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20883,211,1.03 [0.91-1.16],0.6840788871369899
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25299,265,0.99 [0.89-1.11],0.8829808579706673
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27412,128,1.08 [0.93-1.26],0.3068366621157798
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20984,312,1.04 [0.94-1.15],0.4715129451340588
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20780,108,1.04 [0.87-1.23],0.6776366759587138
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21322,650,1.04 [0.97-1.11],0.3271995039886667
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20834,162,0.99 [0.86-1.15],0.9430228501104718
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21274,602,1.00 [0.93-1.08],0.9813270623182292
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27527,39,0.92 [0.68-1.24],0.5939864468086546
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27547,2513,1.06 [1.02-1.09],0.0022090980875593
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25200,166,1.05 [0.91-1.20],0.5181486151442769
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25475,105,0.92 [0.76-1.10],0.3482020229463128
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27382,36,1.05 [0.78-1.41],0.7474869809594062
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24361,147,1.11 [0.96-1.27],0.1553070788414156
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27619,273,1.08 [0.97-1.20],0.1602150879602291
CXCL1,Growth-regulated alpha protein,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20813,141,0.96 [0.82-1.12],0.6187030016840042
